Cargando…
Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A(2A) Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS
The authors in the current work suggested the potential repurposing of omarigliptin (OMR) for neurodegenerative diseases based on three new findings that support the preliminary finding of crossing BBB after a single dose study in the literature. The first finding is the positive results of the dock...
Autores principales: | Ayoub, Bassam M., Michel, Haidy E., Mowaka, Shereen, Hendy, Moataz S., Tadros, Mariam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915074/ https://www.ncbi.nlm.nih.gov/pubmed/33567615 http://dx.doi.org/10.3390/molecules26040889 |
Ejemplares similares
-
Investigation of Pharmacokinetic Parameters of Trelagliptin in Egyptian Volunteers Using Sensitive LC-MS/MS: A Comparative Study with a Japanese Population
por: Mowaka, Shereen, et al.
Publicado: (2021) -
Enhanced Extraction Technique of Omarigliptin from Human Plasma—Applied to Biological Samples from Healthy Human Volunteers
por: Mowaka, Shereen, et al.
Publicado: (2020) -
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
por: Ayoub, Bassam M., et al.
Publicado: (2018) -
Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations
por: Ayoub, Bassam M., et al.
Publicado: (2017) -
Comparative Liquid Chromatographic Study for Concurrent Determination of Canagliflozin and Metformin in Combined Tablets
por: Zaghary, Wafaa A., et al.
Publicado: (2017)